SENVEST CAPITAL INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 285 CAD | 0.00% |
|
0.00% | -8.06% |
| Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
| Apr. 04 | Biolinq Incorporated announced that it has received $58 million in funding from a group of investors | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Senvest Capital Inc. is a Canada-based holding company with interests in investment management and direct investing in public securities and private investments. The Company and its subsidiaries hold investments in equity and real estate holdings that are located predominantly in the United States. The Company's subsidiaries include Senvest Global (KY) L.P., Senvest Global L.P., RIMA Senvest Master Fund GP, L.L.C., Argentina Capital Inc., Pennsylvania Properties Inc., Senvest Technology Partners GP, L.L.C, Senvest Master Fund, L.P., Senvest Technology Partners Master Fund, L.P., and Senvest Cyprus Recovery Investment Fund, L.P.
Calendar
2024-05-06
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -8.06% | 514M | |
| -6.03% | 113B | |
| -3.98% | 87.91B | |
| +20.96% | 63.76B | |
| +5.29% | 61.9B | |
| +10.12% | 42.86B | |
| +7.95% | 40.84B | |
| +18.92% | 34.58B | |
| +5.88% | 25.48B | |
| -5.25% | 22.13B |
- Stock Market
- Equities
- SEC Stock
- News Senvest Capital Inc.
- Senvest Capital Brief: Reported net loss attributable to common shareholders of ($67.0) million or ($27.07) per share for Q3
